Stereotactic radiotherapy (CyberKnife*) for prostate cancer

[Guest guest]

"This paper reports on the largest series of patients treated with CyberKnife* for prostate cancer at one institution.

In the year since we compiled the data, we have continued to be encouraged by the efficacy and toxicity profile. We still have not seen a

local failure in the low or intermediate risk patients, with our early group treated with 35gy having a median followup of 42 months. For two reasons, we have decreased our dose back from 36.25 Gy to 35 Gy.... Click on the below link for the full story:<http://www.urotoday.com/3341/browse_categories/beyond_the_abstract/beyond_the_abstract__stereotactic_body_radiotherapy_for_organconfined_prostate_cancer_by_alan__j_katz_md_jd04022010.html> You're welcome to browse within the

above medical web site, but

you'll be requested to

register, which you can safely do. Non-doctors are welcome and there's never any spam.